Close Menu

NEW YORK (GenomeWeb) – NanoString said today it has entered a comarketing agreement with Leica Biosystems.

Under the agreement, the companies will create a research workflow integrating NanoString's GeoMx Digital Spatial Profiling (DSP) instrument with Leica's Bond RX autostainer. Leica will be able to promote the GeoMx technology to its Bond RX customers, and NanoString will promote the Bond RX system to its GeoMX DSP customers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.